Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
3
×
amgen
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alirocumab
alnylam pharmaceuticals
alopecia areata
amarin
What
drug
3
×
new
3
×
advantages
bar
bio
biotech
black
brings
cancer
cholesterol
clinic
companies
diamond
drugs
eluded
expect
expensive
faces
financial
foe
gamble
healthcare
hint
hopes
inhibitors
ipo
known
lead
leading
lines
lowering
market
medco’s
medicines
molecular
mover
nears
patients
payers
pcsk
Language
unset
3
×
Current search:
drug
×
unset
×
" san francisco blog main "
×
new
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
